CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...

A new experimental drug meant to be taken just once a month could lead to “substantial weight reduction” within a year and ...

MariTide is designed to combine the effects of glucagon-like peptide-1 (GLP-1) receptor activation with glucose-dependent ...

See all the celebrities who've talked about semaglutide and tirzepitide GLP-1 drugs including Ozempic, Mounjaro, Zepbound and Wegovy (including whether or not they've used the drug for weight loss ...

While discussing the use, safety and efficacy of GLP-1 drugs with Dr. Ania Jastreboff on the Jan. 14 episode of “The Oprah Podcast,” the Harpo Productions founder said her entire way of ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

Over 176 weeks, participants taking 15 mg of tirzepatide lost an average 22.9% of their body weight, compared with 19.9% with 10 mg, 15.4% with 5 mg, and 2.1% with placebo (P<0.001), reported Ania ...

News 8 sat down with Dr. Ania Jastreboff, a Yale associate professor, endocrinologist and obesity medicine physician, to discuss these weight loss drugs. She leads the Yale Obesity Research Center ...

New once-a-month drug could treat diabetes and obesity, scientists say. Researchers say experimental drug’s less frequent dosing could improve adherence and offer long-term control ...

M edia maven Oprah Winfrey stirred controversy during a recent “The Oprah Podcast” episode with Yale University obesity medicine physician Dr. Ania Jastreboff. The converoversial conversation ...

The talk-show legend sat down with Dr Ania Jastreboff on her podcast. You may also like. Oprah Winfrey shares real thoughts on Meghan Markle's latest venture.

Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk ...